中文  -   Español  -   Français

PSI-Inc.org

Using the United States' Department of State regional groupings of countries, slightly modified, incident data was analyzed with respect to seven regions of the world. Within the 3,147 pharmaceutical crime incidents, the Institute found:

  • A five percent increase (+5%) in the worldwide incident total
  • Every region experienced a pharmaceutical crime incident
  • 127 countries were impacted by pharmaceutical crime
  • Incidents in the North America region increased over one hundred percent surpassing one thousand incidents

In the adjacent chart, the regions are ranked in order from those experiencing the highest number of incidents to those with the lowest number.

It is important to note that the regions that are more frequently linked to incidents are not necessarily those with weak enforcement and inspection programs. Rather, countries in these regions are effectively identifying pharmaceutical crime through law enforcement activity and inspections by drug regulatory agencies. Many countries in regions with high incident totals are quite transparent in government operations and their activities are known to the media and public.

Those regions with seemingly low incident totals are not necessarily unaffected by or at a lower risk of pharmaceutical crime. Due to competing law enforcement priorities, lack of funding or inadequate regulatory structures, in certain regions of the world, counterfeit medicines often go undetected. It is important to recognize these facts, since they complicate region to region comparisons.

Totals exceed 3,147 incidents because a region is included if it is the "origin, point of seizure or transit, or destination" of illegal pharmaceuticals.